Hydrolysis of 2D Nanosheets Reverses Rheumatoid Arthritis Through Anti-Inflammation and Osteogenesis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39726077.
- Also identified by DOI 10.1002/adma.202415543.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rheumatoid arthritis (RA) is a kind of inflammation homeostasis disorder that dysfunctions the joints. Clinically, medications against RA focus simply on mitigating the focal inflammation, without considering pro-osteogenesis re-modeling of the bone microenvironment. In the present work, 2D layered calcium disilicide nanoparticles (CSNs) are fabricated by facile aqueous exfoliation. The hydrolysis of CSNs produces anti-oxidative H<sub>2</sub>, alkaline Ca(OH)<sub>2</sub>, and silica. These moieties play significant roles in anti-oxidation, anti-inflammation, and pro-osteogenesis resulting in considerably better RA therapeutic consequences than anti-inflammation alone. Hydrogen gas is validated to eliminate excessive hydroxyl radicals and regulate macrophage re-polarization; the generated Ca(OH)<sub>2</sub> can neutralize the acidic microenvironment and inhibit the osteoclast activity; and, the dissolved Ca<sup>2+</sup> can effectively complex with phosphates to mineralize Ca<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub>, promoting the osteogenesis of the focal joint. The multifunctional performances of CSNs are further confirmed in arthritic mouse and rabbit models, providing an advanced and robust therapeutic strategy against RA with high biocompatibility and clinical transformable promises.
Medical subject headings
- Arthritis, Rheumatoid
- Osteogenesis
- Anti-Inflammatory Agents
- Nanoparticles